[Research-Admin] Grant Funding Opportunities

Research Administration research-administration at lists.utsouthwestern.edu
Fri May 29 13:26:22 CDT 2015


[cid:image002.png at 01D08E55.35EDDDD0]

[Please do not reply via email to this courtesy message.]


Dear Research Community,

The following grant funding opportunity announcements may be of interest to you.

Kind regards.

Sponsored Programs Administration
214.648.0860

_____________________________

Subject: Funding Opportunity - CDMRP MS Research - June 4 Deadlines


[NMSS Logo]



Funding Opportunities in MS Research
 DOD - Congressionally Directed Medical Research Program
  Investigator-Initiated Research and Pilot Clinical Trials

Pre-Application Deadline: June 4, 2015







Quick Links


Research Funding<http://r20.rs6.net/tn.jsp?f=001KvIdqsEwymfA_BIy3z0ylCc3D35zAVeAJ0LQFKldl_g4E5B74pcmeA35BknfdnPQy3Ubdj6lo7ox-nyf-MD4suSM8g6-8RY-qXI4n_SiaVEfQciNtcGpJ82-y83PHYBDuc3AVZGCBTMME5tS-kcCEpX91Toijd0XJdBMw1gWSFUctl6QoY5xLvByYMV42kDJeIlUu_Gd0b4KlvfeG7vIAhTni6PNiNCbUQ_OEjvmoK5tmRDoZFYSd6WrOIVvOqeR&c=tiqQVr5lGETNwFS1f358rOlrjH1zcCY5ctOS63xn3EjTOw5CE9bb5g==&ch=u4WGaxQoTndMTK9IuEbZopsLwVXkt8w9QzOorXmbLDU5K8ge0LHuSA==> - National MS Society


Resources for Researchers<http://r20.rs6.net/tn.jsp?f=001KvIdqsEwymfA_BIy3z0ylCc3D35zAVeAJ0LQFKldl_g4E5B74pcmeA35BknfdnPQD1-o92w7vHTTTacdu_kjg3G_yWdgl3pgQK77cqA1UrNGh0JJD-WlxUQmTVr8zn44JU7hojzfwZOsqmNa0hXIyXKb5iZj89CE6Wp87hII8vKLZ9vwvpC3pNzhsUA1u2U3maeb6KTe7LMbaDvP2Ys9__Kc2DRJ-7c7ik3-rmOpMCLTOf5ycz47twbAZ1rI71CHR5fvoIsMbi0=&c=tiqQVr5lGETNwFS1f358rOlrjH1zcCY5ctOS63xn3EjTOw5CE9bb5g==&ch=u4WGaxQoTndMTK9IuEbZopsLwVXkt8w9QzOorXmbLDU5K8ge0LHuSA==>


Research News<http://r20.rs6.net/tn.jsp?f=001KvIdqsEwymfA_BIy3z0ylCc3D35zAVeAJ0LQFKldl_g4E5B74pcmeNtBbPV7tt5ehpEWMaFbGYCg7wnQhTVStoDtjlJDau1u4mQF1gqeVb3muFbof3FB2Wrgb1q23OsmwP3eYhHf08i9L8DaXZ9wopdZXvGBaz3HuDyMBXjxGsEDo_fp5TMqpZdMTpyEjqIa6_xjs3N1p1ulgzHHR6PrCw==&c=tiqQVr5lGETNwFS1f358rOlrjH1zcCY5ctOS63xn3EjTOw5CE9bb5g==&ch=u4WGaxQoTndMTK9IuEbZopsLwVXkt8w9QzOorXmbLDU5K8ge0LHuSA==>


MS Discovery Forum<http://www.msdiscovery.org/>



New Research Funding Opportunities Announced

The Multiple Sclerosis Research Program, managed by the office of Congressionally Directed Medical Research Programs, has announced two new funding opportunities to support research projects that are relevant to the prevention, etiology, pathogenesis, assessment, and treatment of MS:

  *   DoD Multiple Sclerosis Investigator-Initiated Research Award

  *   DoD Multiple Sclerosis Pilot Clinical Trial Award
Pre-Applications required. Deadline: June 4, 2015


Apply or find further information HERE<http://r20.rs6.net/tn.jsp?f=001KvIdqsEwymfA_BIy3z0ylCc3D35zAVeAJ0LQFKldl_g4E5B74pcmeEbLlNhGtvq_gYZRY_iUvJfEDLLtiTrJQeuJzPYHAG__Nxn0zkyqfxv97aQ0jo5HY9ba1jUZSTo6Fi3W08frlb1zWh02lehNxJGJInVvAv0_5ZxG48bBPD7ApZ4IR23qLSkqWagsh-tB0VwoHvJDM0s=&c=tiqQVr5lGETNwFS1f358rOlrjH1zcCY5ctOS63xn3EjTOw5CE9bb5g==&ch=u4WGaxQoTndMTK9IuEbZopsLwVXkt8w9QzOorXmbLDU5K8ge0LHuSA==>







We mobilize people and resources to drive research for a cure and to address the challenges of everyone affected by MS.




National Multiple Sclerosis Society | 733 Third Avenue | New York | NY | 10017



_____________________________

Subject: Deadline Approaching: Open ADDF Funding Opportunities

View email in your browser.<http://us6.campaign-archive1.com/?u=28519dc581b0b3043b827ff2c&id=fb8f636bf8&e=1b83bcaa64>




[https://gallery.mailchimp.com/28519dc581b0b3043b827ff2c/images/ad131ee9-1125-4b05-be7b-b98d8a3a1ad6.png]<http://alzdiscovery.us6.list-manage1.com/track/click?u=28519dc581b0b3043b827ff2c&id=64ead4e40f&e=1b83bcaa64>






[Funding Opportunities: Deadline June 16]<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=15a6730d7b&e=1b83bcaa64>






ApoE RFP
The Alzheimer's Drug Discovery Foundation (ADDF) and the Robert A. and Renée E. Belfer Family Foundation established The ADDF/Belfer ApoE Therapeutics Innovation Program to accelerate the development of novel therapeutics specifically designed to target apoE pathological mechanisms. See full RFP.<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=bfe6cb4cea&e=1b83bcaa64>



PRECLINICAL DRUG DISCOVERY RFP
The Alzheimer's Drug Discovery Foundation (ADDF) seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising preclinical drug discovery and biomarker development programs relevant to Alzheimer's disease, other dementias and cognitive aging. See full RFP.<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=8320b4cbe7&e=1b83bcaa64>



PACT RFP
The ADDF has created the Program to Accelerate Clinical Trials (PACT) to increase the number of innovative drugs tested in humans at the crucial proof of concept stage for Alzheimer's disease. This program will fund biomarker-based, proof-of-concept pilot clinical trials for Alzheimer's. See full RFP. <http://alzdiscovery.us6.list-manage1.com/track/click?u=28519dc581b0b3043b827ff2c&id=713e04fb5c&e=1b83bcaa64>

ADDF/NIH RFP
The ADDF will consider financial assistance for relevant NIH grant applications that were scored but not funded in response to certain NIH funding opportunities. Application deadline is rolling. See full RFP. <http://alzdiscovery.us6.list-manage1.com/track/click?u=28519dc581b0b3043b827ff2c&id=c045ace9fe&e=1b83bcaa64>






[Learn More]<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=f15a27d374&e=1b83bcaa64>











[https://gallery.mailchimp.com/28519dc581b0b3043b827ff2c/images/cd542327-c3a1-4d96-a700-eee5d748038c.png]



[http://cdn-images.mailchimp.com/icons/social-block-v2/dark-facebook-48.png]<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=31f36c73be&e=1b83bcaa64>

Share<http://alzdiscovery.us6.list-manage.com/track/click?u=28519dc581b0b3043b827ff2c&id=eeb305feec&e=1b83bcaa64>




[http://cdn-images.mailchimp.com/icons/social-block-v2/dark-twitter-48.png]<http://alzdiscovery.us6.list-manage1.com/track/click?u=28519dc581b0b3043b827ff2c&id=4d91dc9a46&e=1b83bcaa64>

Tweet<http://alzdiscovery.us6.list-manage2.com/track/click?u=28519dc581b0b3043b827ff2c&id=3acc1e3498&e=1b83bcaa64>




[http://cdn-images.mailchimp.com/icons/social-block-v2/dark-forwardtofriend-48.png]<http://us6.forward-to-friend.com/forward?u=28519dc581b0b3043b827ff2c&id=fb8f636bf8&e=1b83bcaa64>

Forward to Friend<http://us6.forward-to-friend.com/forward?u=28519dc581b0b3043b827ff2c&id=fb8f636bf8&e=1b83bcaa64>












_____________________________

Subject: Thome Awards for Alzheimer's Therapeutics



Having trouble viewing this email? Click here <http://campaign.r20.constantcontact.com/render?ca=5a58a0e6-b876-4698-9991-5b4794cff45e&c=1c705150-35c1-11e3-9d10-d4ae528eb986&ch=1dfa25a0-35c1-11e3-9d57-d4ae528eb986>











Funding for Alzheimer's Disease
Drug Discovery Research



[New AD cells]




Initial Proposal Deadline:

  *   Friday, June 26, 2015
  *   12:00 Noon, US Eastern Time


Award Amount and Funding Period:

  *   Two-year projects of $500,000
  *   Up to 6 awards will be funded
  *   Funding begins on December 31, 2015


Guidelines and Materials:
www.tmfgrants.org/ThomeAD<http://r20.rs6.net/tn.jsp?f=001Npqb4UUmV4hed9Tty2IoO3nW1klnTsPICy6vaxCNCVjbAHRLKZpfyF7TfpPodlIhwFcKx510iL75ssseZ_g45bXYzz8cMesw-WJET4Jg7YxaIMtpBLUd6gmWKuz3z9Y010Mv598QJ2txYop4kB5m3bZOW7qXkzotStY4TwcI_AKqXTk5hlTFVQ==&c=PJxsSgPg9KkygjJ9eSD9uBeXGaHcII5fcdNYvpTqiObbnQyAcbypgQ==&ch=HnaPOFQtnFddvO9OubWdSzoiRhBzOE9G4xNI45leZt0u3x6xjBew7g==>





Edward N. & Della L. Thome Memorial
Foundation, Bank of America, N.A., Trustee, Awards Program in Alzheimer's Disease Drug Discovery Research



The Edward N. & Della L. Thome Memorial Foundation was created in 2002 to advance the health of older adults through the support of direct service projects and medical research on diseases and disorders affecting older adults.



The goal of the 2015 Awards Program in Alzheimer's Disease (AD) Drug Discovery Research is to support innovative drug discovery research that will lead to improved therapies for individuals suffering from Alzheimer's disease.



Researchers dedicated to the validation and testing of target compounds and therapeutic agents, including biologics and small molecules, are encouraged to apply. Consideration will be given to research based on the amyloid hypothesis as well as alternative pathogenic mechanisms such as APOE, inflammatory and tau-related pathways.



Basic research or new target discovery, genetic studies, biomarker research, neuro-imaging and clinical studies are currently outside the scope of this Program.





[http://ih.constantcontact.com/fs183/1101852586778/img/325.gif]









[The Medical Foundation - A division of Health Resources in Action]


The Edward N. & Della L. Thome Memorial Foundation Awards Program is administered by The Medical Foundation division.

Questions: 617-279-2240, x710 or EJohnstone at hria.org<mailto:ejohnstone at hria.org>



The Medical Foundation, a Division of HRiA | 95 Berkeley Street, Suite 208 | Boston | MA | 02116




_____________________________

Subject: Just Released! FY15 DoD PCRP and GWIRP Program Announcements


This e-mail is to notify the research community of recently released funding opportunities from the Department of Defense (DoD) for Prostate Cancer Research Program (PCRP) and Gulf War Illness Research Program (GWIRP) managed by the office of Congressionally Directed Medical Research Programs (CDMRP).

Prostate Cancer Research Program (PCRP):

         Collaborative Undergraduate HBCU Student Summer Training Program Award

         Exceptional Responders Award

         Idea Development Award

         Impact Award

         Dr. Barbara Terry-Koroma Health Disparity Research Award

         Physician Research Training Award

         Postdoctoral Training Award

Gulf War Illness Research Program (GWIRP):

Gulf War Illness Epidemiology Research Award

New Investigator Award

Investigator-Initiated Research Award

Innovative Treatment Evaluation Award

Clinical Trial Award

Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov<http://www.grants.gov/>), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org).

All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (http://cdmrp.army.mil<http://cdmrp.army.mil/>).

Subsequent notifications will be sent when additional funding opportunities are released. A listing of all open CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Submission is a two-step process requiring both (1) pre-application submission through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/) and (2) application submission through Grants.gov (http://www.grants.gov/). Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov.

eBRAP is a multifunctional web-based system that allows PIs to submit their pre-applications electronically through a secure connection, to view and edit the content of their pre-applications and full applications, to receive communications from the CDMRP, and to submit documentation during award negotiations and period of performance. A key feature of eBRAP is the ability of an organization's representatives and PIs to view and modify the Grants.gov application submissions associated with them. eBRAP will validate Grants.gov application files against the specific Program Announcement/Funding Opportunity requirements and discrepancies will be noted in an email to the PI and in the Full Application Files tab in eBRAP. It is the applicant's responsibility to review all application components for accuracy as well as ensure proper ordering as specified in this Program Announcement/Funding Opportunity.

Please do not respond directly to this message.

CDMRP also provides news and updates through Twitter and YouTube.

Follow CDMRP on Twitter: https://twitter.com/CDMRP

Subscribe to CDMRP on YouTube: http://www.youtube.com/CDMRP
_____________________________

Subject: Breast Cancer Research Funding Opportunities from Susan G. Komen


[https://gallery.mailchimp.com/921a84188ebe28608151acdcb/images/58339412-9ab5-4b96-a08c-ef38cd4187c3.jpg]

View this email in your browser<http://us4.campaign-archive2.com/?u=921a84188ebe28608151acdcb&id=63d30cba06&e=d1559080f0>

KOMEN ANNOUNCES CALL FOR RESEARCH PROPOSALS FROM EARLY CAREER INVESTIGATORS: Now accepting pre-applications - Due June 17, 2015
1. Career Catalyst Research (CCR) Grants<http://komen.us4.list-manage2.com/track/click?u=921a84188ebe28608151acdcb&id=911519ff8c&e=d1559080f0>
2. Postdoctoral Fellowships (PDF)<http://komen.us4.list-manage.com/track/click?u=921a84188ebe28608151acdcb&id=0271f7bc78&e=d1559080f0>
3. Graduate Training in Disparities Research (GTDR) Grants<http://komen.us4.list-manage.com/track/click?u=921a84188ebe28608151acdcb&id=0a1d746e8a&e=d1559080f0>
Update on Biosketch requirements: Komen accepts all NIH formatted Biosketches including the new format. Biosketch page limits have been expanded to 5 pages to accommodate those Applicants using the new format, and funding announcements have been updated accordingly.



[https://gallery.mailchimp.com/921a84188ebe28608151acdcb/images/a8e04783-184e-49d8-98ec-c4c006799b99.jpg]



1. Career Catalyst Research (CCR) Grants<http://komen.us4.list-manage1.com/track/click?u=921a84188ebe28608151acdcb&id=a7ec52548b&e=d1559080f0>

  *   Eligibility: Applications are open to junior faculty members working at academic institutions who have no more than six years of experience within their faculty appointment
  *   Funding Level: Up to $300,000 over 2 years or $450,000 over 3 years.
  *   Training Requirements: Applicants/PIs must propose a mentor committee whose purpose is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Applicant/PI's career advancement. At least one mentor must be at the same institution as the PI and serve as the onsite representative for the entire mentor committee.
  *   Grant Intent: CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer.  These grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers.
Two Research Focus Areas are included in this mechanism:

  *   CCR-Clinical Research - for clinical faculty proposing clinical research (as defined within the RFA); and
  *   CCR-Basic/Translational Research - for basic or clinical faculty proposing laboratory-based biomedical research.




2. Postdoctoral Fellowships (PDF)<http://komen.us4.list-manage1.com/track/click?u=921a84188ebe28608151acdcb&id=1f25510997&e=d1559080f0>

  *   Eligibility: Applications are open to postdoctoral fellows who have completed their doctoral degree and are at academic institutions, no more than 5 years after the date of their degree confirmation, or 5 years after completion of their residency (for physicians).
  *   Funding Level: Up to $120,000 over 2 years or $180,000 over 3 years.
  *   Training Requirements: Applicants/PIs must include a Lead Mentor who currently conducts breast cancer research at the same academic institution with the postdoctoral fellow.  The primary purpose of the Lead Mentor and Co-Mentor (if applicable) is to provide the research, scientific, clinical, management, and leadership guidance necessary to foster the Applicant/PI's career advancement.
  *   Grant Intent: Seek to attract and support promising scientists who are embarking on careers dedicated to breast cancer research.  PDF grants provide support for basic research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer.
Two Research Focus Areas are included in this mechanism:

  *   PDF-Clinical Research - for clinical faculty proposing clinical research (as defined within the RFA); and
  *   PDF-Basic/Translational Research - for basic or clinical faculty proposing laboratory-based biomedical research.



3. Graduate Training in Disparities Research (GTDR) Grants<http://komen.us4.list-manage.com/track/click?u=921a84188ebe28608151acdcb&id=36aaed2739&e=d1559080f0>

  *   Eligibility: Applications are open to researchers with a doctoral degree at academic institutions who are conducting breast cancer disparities research and are committed to support a training program with a minimum of 3 graduate students/trainees (those in a masters and/ or doctoral program) per year.
  *   Funding Level: Up to $135,000 per year for up to 3 years for a total of $405,000.
  *   Training Requirements: The proposed research training program should leverage the current training and research activities available at the applicant institution while also providing new training opportunities that are not currently offered. The program should provide a combination of didactic coursework and hands-on laboratory, clinical and/or public health research experience.  Strong preference will be given to programs that provide a solid plan for recruiting trainees from populations affected by disparities in breast cancer outcomes.
  *   Grant Intent: Intended to establish and/or to sustain a training program for graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. By providing funding to outstanding training programs, Komen seeks to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research.




KEY DATES

  *   Application System Opens: May 6, 2015
  *   Pre-Application Due: June 17, 2015, by 1 p.m., Eastern Standard Time
  *   Pre-Application Decision: September 16, 2015
  *   Full Application Due: November 9, 2015, by 1 p.m., Eastern Standard Time
  *   Award Notification: On or around April 15, 2016



[https://gallery.mailchimp.com/921a84188ebe28608151acdcb/images/d31a818c-876b-4921-a54c-517e5d686abe.jpg]

PATIENT VOICE
We are committed to including the breast cancer patient voice in our funded research and have always encouraged applicants to collaborate with Patient Advocates. Patient Advocates bring a unique perspective to help researchers in their projects.  This year as part of Komen's commitment to include the patient perspective, we will require applicants to work with Patient Advocates  at the Full Application stage (due November 9, 2015) of the application process.





Details on all Funding Mechanisms ARE available at www.komen.org/RFA<http://komen.us4.list-manage1.com/track/click?u=921a84188ebe28608151acdcb&id=a1b6a11d6d&e=d1559080f0>.
If you would like join our mailing list, please email helpdesk at komengrantsaccess.org<mailto:helpdesk at komengrantsaccess.org> and ask to be added.
At Susan G. Komen, we are committed to ENDING breast cancer forever by ENERGIZING SCIENCE to find the cures and ensuring QUALITY CARE for all people, everywhere.



Our mailing address is:
Susan G. Komen®
5005 LBJ Freeway
Suite 250
Dallas, TX 75244




_____________________________

Subject: Fw RFA DKR Fund


[cid:image042.jpg at 01D09870.D6457660]

IMPORTANT NOTICE
May 26, 2015
The DKR Fund announces the reopening of the 2015 grant application period from this date through June 30, 2015.

Although the fund received many important and meritorious proposals, it became apparent as we opened the review process that some unintended confusion arose in the interpretation of qualification related to the time period lapse post terminal degree.

In the interest of inclusion, transparency and fairness, the fund will accept proposals from those applicants who are twelve (12) years post terminal degree or six (6) years from completion of last training such as fellowships or residencies.
2015 Request for Funding Proposal
The Darrell K Royal Fund for Alzheimer's Research (DKR Fund) represents a commitment to excellence in Research and Care for Texans in an attempt to cure Alzheimer's Disease (AD) in our lifetime, expand research to target Mild Cognitive Impairment (MCI) and to expand the paradigms of assess and care for Texans enabling exposure to preventive treatment strategies aimed at combatting the epidemic of AD and related disorders.

The Darrell K Royal Research Fund for Alzheimer's Disease announces its 2nd annual Request ForProposal (RFP). This RFP is designed to support early-to-mid career Texas-based scientists. This RFP seeks to support collaborative research endeavors across the state of Texas as well as throughout the United States and to foster a translational based research structure.

Eligibility
The principal investigator (PI) must be at the Assistant or Associate Professor level within a Texas-based institution and within twelve (12) years of completion of their terminal degree (e.g. Ph.D. or M.D. or six (6) years from completion of last training such as fellowships or residencies). PIs can possess degrees in any field as long as the topic is relevant to

neurodegeneration and must be able to demonstrate a track record of productivity appropriate for their designated research goals. Inter-institutional collaborations are encouraged, which may include collaborators outside of Texas.

Funding Priorities
The DKR Fund is interested in novel, innovative and cutting edge approaches to Alzheimer's disease and related disorders. The DKR Fund 2015 grant cycle is particularly interested in but not limited to (1) prevention of cognitive impairment and (2) dementia resulting from traumatic brain injury. Studies that pilot novel mechanisms and novel therapeutic interventions are particularly encouraged.  DKR Fund also has an interest in supporting work in MCI, cognitive impairment related to traumatic brain injury (TBI), as well as work with Veterans and underserved minority populations.   DKR Fund also has interest in supporting work in MCI, cognitive impairment related to traumatic brain injury (TBI), as well as work with Veterans and underserved minority populations.

Application Submission Guidelines
DKR fund will provide support for up to three years of research, with potential for future follow-up funding to be considered. Direct costs are capped at $50,000 per year with indirect funds capped at 10% (in addition to the direct costs). DKR Fund reserves the right to reallocate funds as deemed appropriate based on the quantity and quality of the applicant pool. Funds can be utilized to support research staff, purchase necessary small equipment and supplies, and other direct-research relevant expenditures. Funds can be utilized for travel to present findings at an appropriate scientific meeting (capped at $3,000 per year). Funds cannot be utilized to support faculty salaries. Awardees will be expected to present on their research topic and findings during the funding period for the DKR award.  DKR Fund is prepared to offer up to 5 multi year awards of $150,000 each to worthy projects.

Application Guidelines
Applications are expected to use the following guidelines. Use 11 point font or larger text (Arial, Helvetica, or Times New Roman) with no more than 15 characters and six lines per inch. Use standard paper size (8.5 x 11) and at least 0.5 inch margins (top, bottom, left and right) for all pages. Applications are encouraged to follow an NIH R03 format style and should be no more than 10 pages inclusive of the following areas: Specific Aims, Research Strategy, Environment and Available Resources, Literature Cited, human or animal protections (if applicable), and data management/sharing plans (other sections can be added but must fit within the 10pg limit).

NIH-style biosketchs are required (4 page limit) for all PIs and collaborating investigators.

Files should be submitted in PDF format with clearly identifiable names that include the PI's last name.

Application Deadline
June 30, 2015 with anticipated award announcement October 20, 2015 and funding to begin November 1, 2015. If proposal made in the name of more than one applicant, DKR Fund will provide travel for one individual to represent proposal at the award ceremony.

Submit completed application and separate budget to:

DKR Fund
Mrs. Edith Royal & Grants Committee
info at dkrfund.org<mailto:info at dkrfund.org>
subject line to read: Grant app (LAST NAME of APPLICANT)
_____________________________

Subject: DoD Military Burn Research Program

Department of Defense Military Burn Research Program
Funding Opportunity for Fiscal Year 2015 (FY15)


The FY15 Defense Appropriations Act provides $8 million (M) to the Department of Defense Military Burn Research Program (MBRP) to support high-impact burn injuries research.  Applications to the Fiscal Year 2015 (FY15) Military Burn Research Program (MBRP) are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA).  The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
The MBRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications.  FY15 MBRP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the Grants.gov website in late June or early July 2015.  Pre-application and application deadlines will be available when the Program Announcements are released.  This pre-announcement should not be construed as an obligation by the government.
Topic Areas:  The MBRP encourages applications that specifically address the critical needs of the burn research community in one of the FY15 Topic Areas.  The MBRP will solicit research applications for the following FY15 Topics Areas:
1.                                                    Fluid Resuscitation Studies (Human)

a)    Through multicenter prospective observational studies (retrospective or prospective), demonstrate the impact of various fluid resuscitation rates and techniques, as well as various adjunctive therapies (high-dose/low-dose vitamin C, albumin timing, etc.) on clinically relevant outcomes during acute burn resuscitation.

2.                                                    Organ Failure Studies (Human)
a)    Through clinical studies, provide insight into the epidemiology, prevention, early detection, and/or treatment of single or multiple organ failure in the burn/trauma patient.

b)    Provide a systematic approach to define sepsis in burns and the impact of sepsis-related outcomes through the identification and establishment of best practice while evaluating longitudinal adherence to established standards.

3.    Wound Healing (Animal/Human)
a)    Determine specific physiological factors that result in delayed wound healing, such as shock, edema, immune system dysregulation, etc.
b)    Evaluate or develop strategies (dressing, topicals, biologics, etc.) that optimize healing of acute burn wounds.

c)    Identify diagnostic predictors (biomarkers, imaging techniques, physical wound changes, etc.) that can be used to indicate failure of wound healing.

4.    Prolonged Field Care and Delayed Evacuation (Animal/Human)
a)    Determine the clinical impact of delayed definitive therapy and/or resuscitation in a burn injury animal model.

b)    Through observational or retrospective studies, describe the impact of delayed care at intermediary facilities, prolonged time to initial treatment, and/or extended transport times on short- and long-term patient outcomes (days on ventilator, development of organ complications, compartment syndrome, limb loss, infection, etc.).

5.    Short- and Long-Term Functional Outcomes

a)    Through retrospective or prospective studies, identify issues that effect, as well as strategies to improve, physical and/or mental functional outcomes (both short- and long-term).  Examples of items to include are social reintegration, duration in intensive care units, range of motion in the affected limb(s), number and types of procedures performed, the use of coping strategies/interventions to mitigate post-traumatic stress disorder, and other strategies that help improve patient outcomes after discharge.

Burn Injuries Research Award
Independent investigators at all academic levels (or equivalent)
·         Supports innovative approaches to accelerate the translation of advances in knowledge into new standards of care for the treatment of the injured Warfighter who sustains burn injuries.
·         Must specifically address at least one of the FY15 Topic Areas
·         Research that is already supported by preliminary data and has the potential to make significant advancements toward clinical translation is required for Funding Level 1.
·         Advanced translational studies that have the potential for near-term clinical investigation are required for Funding Level 2.
·         Clinical trials are allowed.
Preproposal is required; application submission is by invitation only
Funding Level 1
·         The maximum period of performance is 3 years.
·         The maximum allowable funding for the entire period of performance is $750,000 in total costs.
Funding Level 2
·         The maximum period of performance is 4 years.
The maximum allowable funding for the entire period of performance is $2 million in total costs.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government's single-entry portal, Grants.gov<http://www.grants.gov/>.  Submission deadlines are not available until the Program Announcements are released.  Requests for email notification of the Program Announcements release may be sent to help at cdmrp.org<mailto:help at cdmrp.org>.  Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the MBRP or other CDMRP-administered programs, please visit the CDMRP website<http://cdmrp.army.mil> (http://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs at mail.mil<mailto:usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs at mail.mil>


_______________________________________ END _______________________


________________________________

UT Southwestern


Medical Center



The future of medicine, today.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 74992 bytes
Desc: image001.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image007.png
Type: image/png
Size: 37040 bytes
Desc: image007.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image026.gif
Type: image/gif
Size: 43 bytes
Desc: image026.gif
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment.gif>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image027.jpg
Type: image/jpeg
Size: 63568 bytes
Desc: image027.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image030.gif
Type: image/gif
Size: 2718 bytes
Desc: image030.gif
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0001.gif>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image042.jpg
Type: image/jpeg
Size: 7199 bytes
Desc: image042.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0001.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image033.jpg
Type: image/jpeg
Size: 49761 bytes
Desc: image033.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0002.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image036.jpg
Type: image/jpeg
Size: 67453 bytes
Desc: image036.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0003.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image004.jpg
Type: image/jpeg
Size: 3661 bytes
Desc: image004.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0004.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image006.png
Type: image/png
Size: 14609 bytes
Desc: image006.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0002.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image009.png
Type: image/png
Size: 2993 bytes
Desc: image009.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0003.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image011.jpg
Type: image/jpeg
Size: 7922 bytes
Desc: image011.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0005.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image013.png
Type: image/png
Size: 921 bytes
Desc: image013.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0004.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image015.png
Type: image/png
Size: 1015 bytes
Desc: image015.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0005.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image017.png
Type: image/png
Size: 1040 bytes
Desc: image017.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0006.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image031.png
Type: image/png
Size: 167 bytes
Desc: image031.png
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0007.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image032.jpg
Type: image/jpeg
Size: 3738 bytes
Desc: image032.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0006.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image035.jpg
Type: image/jpeg
Size: 5519 bytes
Desc: image035.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0007.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image040.jpg
Type: image/jpeg
Size: 22901 bytes
Desc: image040.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0008.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image041.jpg
Type: image/jpeg
Size: 6089 bytes
Desc: image041.jpg
URL: <http://lists.utsouthwestern.edu/pipermail/research-administration/attachments/20150529/85ae07a2/attachment-0009.jpg>


More information about the Research-Administration mailing list